ZA909350B - 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders - Google Patents
1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disordersInfo
- Publication number
- ZA909350B ZA909350B ZA909350A ZA909350A ZA909350B ZA 909350 B ZA909350 B ZA 909350B ZA 909350 A ZA909350 A ZA 909350A ZA 909350 A ZA909350 A ZA 909350A ZA 909350 B ZA909350 B ZA 909350B
- Authority
- ZA
- South Africa
- Prior art keywords
- substituted
- phenyl
- alkyl
- carbons
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/372,009 US5001160A (en) | 1988-04-28 | 1989-06-27 | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
AT90312632T ATE127117T1 (de) | 1988-04-28 | 1990-11-20 | 1-aryl-1-hydroxy-1-substituierte-3-(4- substituierte-1-piperazinyl)-2-propanone und ihre verwendung bei der behandlung von blasenstörungen neurologischen ursprungs. |
ES90312632T ES2079449T3 (es) | 1988-04-28 | 1990-11-20 | 1-aril-1-hidroxi-1-sustituido-3-(4-sustituido-1-piperazinil)-2-propanonas y su utilizacion en el tratamiento de los trastornos neurogenicos de la vejiga. |
DE69022058T DE69022058T2 (de) | 1988-04-28 | 1990-11-20 | 1-Aryl-1-hydroxy-1-substituierte-3-(4-substituierte-1-piperazinyl)-2-propanone und ihre Verwendung bei der Behandlung von Blasenstörungen neurologischen Ursprungs. |
CA002030397A CA2030397C (fr) | 1988-04-28 | 1990-11-20 | Les 1-aryl-hydroxy-1-substituant-3-(4-substituant- 1-piperazinyl)-2-propanones et leur utilisation pour le traitement de troubles nevralgiques de la vessie |
EP90312632A EP0486734B1 (fr) | 1988-04-28 | 1990-11-20 | 1-Aryl-1-hydroxy-1-substitué-3-(4-substitué-1-pipérazinyl)-2-propanones et leur utilisation dans le traitement des troubles neurogéniques de la vessie |
ZA909350A ZA909350B (en) | 1988-04-28 | 1990-11-21 | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
AU67005/90A AU634604B2 (en) | 1988-04-28 | 1990-11-26 | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl-2-propanones and their use in treatment of neurogenic bladder disorders |
JP2321328A JPH0764833B2 (ja) | 1988-04-28 | 1990-11-27 | 1―アリール―1―ヒドロキシ―1―置換―3―(4―置換―1―ピペラジニル)―2―プロパノン |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18764988A | 1988-04-28 | 1988-04-28 | |
US07/372,009 US5001160A (en) | 1988-04-28 | 1989-06-27 | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
ZA909350A ZA909350B (en) | 1988-04-28 | 1990-11-21 | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
AU67005/90A AU634604B2 (en) | 1988-04-28 | 1990-11-26 | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl-2-propanones and their use in treatment of neurogenic bladder disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA909350B true ZA909350B (en) | 1991-09-25 |
Family
ID=40149700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA909350A ZA909350B (en) | 1988-04-28 | 1990-11-21 | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
Country Status (9)
Country | Link |
---|---|
US (1) | US5001160A (fr) |
EP (1) | EP0486734B1 (fr) |
JP (1) | JPH0764833B2 (fr) |
AT (1) | ATE127117T1 (fr) |
AU (1) | AU634604B2 (fr) |
CA (1) | CA2030397C (fr) |
DE (1) | DE69022058T2 (fr) |
ES (1) | ES2079449T3 (fr) |
ZA (1) | ZA909350B (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5001160A (en) * | 1988-04-28 | 1991-03-19 | Marion Laboratories, Inc. | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
US6482837B1 (en) | 1998-04-24 | 2002-11-19 | University Of Rochester | Antimuscarinic compounds and methods for treatment of bladder diseases |
JP2004043433A (ja) * | 2002-04-26 | 2004-02-12 | Kitai Kagi Kofun Yugenkoshi | モルフォリノケトン誘導体及びその用途 |
AU2002345266B2 (en) | 2002-07-08 | 2009-07-02 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
CA2513188A1 (fr) * | 2003-01-16 | 2004-08-05 | University Of Rochester | Composes antimuscariniques quaternaires destines au traitement de maladies vesicales |
US7488748B2 (en) * | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
WO2004089898A1 (fr) * | 2003-04-09 | 2004-10-21 | Ranbaxy Laboratories Limited | Derives d'azabicyclo hexane substitues en tant qu'antagonistes de recepteurs muscariniques |
US20070021487A1 (en) * | 2003-04-11 | 2007-01-25 | Mohammad Salman | Azabicyclo derivatives as muscarinic receptor antagonists |
WO2006005980A1 (fr) * | 2004-06-16 | 2006-01-19 | Ranbaxy Laboratories Limited | Derives de xanthine utilises en tant qu'antagonistes du recepteur muscarinique |
WO2006018708A2 (fr) * | 2004-08-19 | 2006-02-23 | Ranbaxy Laboratories Limited | Derives de pyrrolidine utilises en tant qu'antagonistes des recepteurs muscariniques |
EP1794161A2 (fr) * | 2004-09-24 | 2007-06-13 | Ranbaxy Laboratories Limited | Antagonistes des recepteurs muscariniques |
US20090105221A1 (en) * | 2004-09-29 | 2009-04-23 | Ranbaxy Laboratories Limited | Muscarinic receptor antagonists |
WO2006054162A1 (fr) * | 2004-11-19 | 2006-05-26 | Ranbaxy Laboratories Limited | Antagonistes azabicycliques des recepteurs muscariniques |
US20100035954A1 (en) * | 2004-12-15 | 2010-02-11 | Mohammad Salman | Acid addition salts of muscarinic receptor antagonists |
WO2006117754A1 (fr) * | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | Derives d'azabicyclo [3.1.0] hexane 3,6-disubstitues utilises comme antagonistes du recepteur muscarinique |
RU2008119323A (ru) | 2005-10-19 | 2009-11-27 | Рэнбакси Лабораториз Лимитед (In) | Фармацевтические композиции мускаринового рецептора |
US20090010923A1 (en) * | 2007-04-24 | 2009-01-08 | University Of Maryland, Baltimore | Treatment of cancer with anti-muscarinic receptor agents |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3125577A (en) * | 1964-03-17 | N-substttuted piperazinoalkyl | ||
US2835676A (en) * | 1953-07-14 | 1958-05-20 | Merck & Co Inc | Gamma-keto-tertiary amines and derivatives thereof |
US3073842A (en) * | 1957-07-22 | 1963-01-15 | Endo Lab | 1, 1 diphenyl-1-hydrocarbonoxy, 4-tertiary amino 2-butanones |
US3157656A (en) * | 1960-07-20 | 1964-11-17 | Olin Mathieson | Heterocyclic compounds |
US3073854A (en) * | 1960-11-28 | 1963-01-15 | California Research Corp | Trimethyllead methyl thioglycolate |
US3395146A (en) * | 1965-02-11 | 1968-07-30 | Warner Lambert Pharmaceutical | 4-substituted-2-benzhydryl-2-butanol derivatives |
US3873546A (en) * | 1974-02-06 | 1975-03-25 | Abbott Lab | Catalytic reduction of 4-methyl-{62 ,{62 -diphenyl-1-piperazine ethanol |
NL8202636A (nl) * | 1982-06-29 | 1984-01-16 | Gist Brocades Nv | Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten. |
US5001160A (en) * | 1988-04-28 | 1991-03-19 | Marion Laboratories, Inc. | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
-
1989
- 1989-06-27 US US07/372,009 patent/US5001160A/en not_active Expired - Lifetime
-
1990
- 1990-11-20 ES ES90312632T patent/ES2079449T3/es not_active Expired - Lifetime
- 1990-11-20 CA CA002030397A patent/CA2030397C/fr not_active Expired - Lifetime
- 1990-11-20 AT AT90312632T patent/ATE127117T1/de not_active IP Right Cessation
- 1990-11-20 EP EP90312632A patent/EP0486734B1/fr not_active Expired - Lifetime
- 1990-11-20 DE DE69022058T patent/DE69022058T2/de not_active Expired - Lifetime
- 1990-11-21 ZA ZA909350A patent/ZA909350B/xx unknown
- 1990-11-26 AU AU67005/90A patent/AU634604B2/en not_active Ceased
- 1990-11-27 JP JP2321328A patent/JPH0764833B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2030397C (fr) | 1996-06-11 |
JPH05125068A (ja) | 1993-05-21 |
US5001160A (en) | 1991-03-19 |
ATE127117T1 (de) | 1995-09-15 |
EP0486734B1 (fr) | 1995-08-30 |
JPH0764833B2 (ja) | 1995-07-12 |
ES2079449T3 (es) | 1996-01-16 |
DE69022058D1 (de) | 1995-10-05 |
AU634604B2 (en) | 1993-02-25 |
CA2030397A1 (fr) | 1992-05-21 |
EP0486734A1 (fr) | 1992-05-27 |
DE69022058T2 (de) | 1996-04-25 |
AU6700590A (en) | 1992-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA909350B (en) | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders | |
NZ240676A (en) | Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof | |
NZ284654A (en) | Oxazolyl substituted 3,5-dioxo-oxadiazolidine or 2,4-dioxo-thiazolidine derivatives and medicaments | |
DE3660286D1 (en) | Arylcyclobutylalkyl amines and their use as antidepressive medicines | |
DK0518558T3 (da) | 1-methylcarbapenemderivater, deres fremstilling og deres anvendelse som antibiotika | |
NO930783L (no) | Kondenserte heterocykliske ketonderivater deres fremstilling og anveendelse | |
ZA948061B (en) | Galanthamine derivatives a process for their preparation and their use as medicaments | |
GB1116692A (en) | A method for producing sydnonimine derivatives | |
BG103426A (en) | Derivatives of substituted 4-biphenyl-4-hydroxy-oil acids as inhibitors of matrix metalloproteases | |
GB8705780D0 (en) | Anticancer compounds | |
ATE109770T1 (de) | Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten. | |
ATE69605T1 (de) | Azolylpropenyl- und azolylmethyloxiran-derivate und diese enthaltende fungizide. | |
IL75987A0 (en) | 1,6-naphthyridine derivatives,their preparation and pharmaceutical compositions containing them | |
GB1373537A (en) | Aminoalkoxy-benzylidene 2-h-benzothiazine-3-4h-ones and related compounds | |
FR2479219B1 (fr) | ||
DE3163803D1 (en) | 2-methyl-5-thiazole-methylamine and carboxamide derivatives | |
EP0176049A3 (en) | Aminoalkylnaphtalene derivatives having pharmacological activities | |
DE69011748D1 (de) | Biphenyl-Derivate, Verfahren zu deren Herstellung und deren Zwischenprodukte. | |
IE40722B1 (en) | Indolopiperdino-alkylthiazines | |
ES8102126A1 (es) | Procedimiento para la produccion e una composicion sinergis-tica a base de derivados de naftiridina | |
GR3000419T3 (en) | 3-iminopyridazine derivatives, process for their preparation and pharmaceutical compositions containing them | |
FR2781155B1 (fr) | Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation | |
ATE44741T1 (de) | 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere. | |
IT1109120B (it) | N propargil piperonilamina e suoi sali di addizione particolarmente utilizzabili come agenti attivi sul sistema nervoso centrale o sul sistema cardiovascolare | |
TH1208A (fr) |